Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
International
●International guideline on dose prioritization and acceptance criteria in radiation therapy planning for nasopharyngeal carcinoma (2019)
●Society for Immunotherapy of Cancer (SITC): Consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC) (2019)
Canada
●British Columbia (BC) Cancer: Guidelines for head and neck cancer
United States
●American Society of Clinical Oncology (ASCO): Guideline for management of salivary gland malignancy (2021)
●ASCO and Chinese Society of Clinical Oncology (CSCO): Chemotherapy in combination with radiotherapy for definitive-intent treatment of stage II-IVA nasopharyngeal carcinoma – Guideline (2021)
●ASCO: Diagnosis and management of squamous cell carcinoma of unknown primary in the head and neck – Guideline (2020)
●ASCO: Management of the neck in squamous cell carcinoma of the oral cavity and oropharynx – Clinical practice guideline (2019)
●ASCO: Human papillomavirus testing in head and neck carcinomas – Clinical practice guideline endorsement of the College of American Pathologists (CAP) guideline (2018)
●CAP: Human papillomavirus testing in head and neck carcinomas guideline (2018)
●American Society for Radiation Oncology (ASTRO): Radiation therapy for oropharyngeal squamous cell carcinoma – An evidence-based clinical practice guideline (2017)
●ASCO: Head and neck cancer survivorship care guideline – Clinical practice guideline endorsement of the American Cancer Society (ACS) guideline (2017)
●ASCO: Radiation therapy for oropharyngeal squamous cell carcinoma – Endorsement of the ASTRO evidence-based clinical practice guideline (2017)
●ASCO: Use of larynx-preservation strategies in the treatment of laryngeal cancer – Clinical practice guideline, update (2017)
Europe
●European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT)/Paediatric Rare Tumours Network - European Registry (PARTNER): Nasopharyngeal carcinoma in children and adolescents – Diagnostic and therapeutic recommendations (2021)
●EXPeRT/PARTNER: Salivary gland carcinoma in children and adolescents – Diagnosis and treatment recommendations (2021)
●European Head and Neck Society (EHNS)-European Society for Medical Oncology (ESMO)-European Society for Radiotherapy and Oncology (ESTRO): Squamous cell carcinoma of the oral cavity, larynx, oropharynx, and hypopharynx – Clinical practice guidelines for diagnosis, treatment, and follow-up (2020)
●ESMO-European Reference Network on Rare Adult Solid Cancers (EURACAN): Nasopharyngeal carcinoma – Clinical practice guidelines for diagnosis, treatment, and follow-up (2020)
United Kingdom
●National Institute for Health and Care Excellence (NICE): Quality standard on head and neck cancer (2017)
●United Kingdom multidisciplinary guidelines on head and neck cancer (2016)
India
●Pan-Asian adaptation of the European Head and Neck Society (EHNS)-European Society for Medical Oncology (ESMO)-European Society for Radiotherapy and Oncology (ESTRO) clinical practice guidelines for the diagnosis, treatment, and follow-up of patients with squamous cell carcinoma of the head and neck (2021)
●Indian clinical practice consensus guidelines for the management of nasopharyngeal cancer (2020)
●Indian clinical practice consensus guidelines for the management of oropharyngeal cancer (2020)
●Indian Council of Medical Research (ICMR): Consensus document for management of larynx and hypopharynx cancers (2017)
Australia–New Zealand
●Clinical Oncology Society of Australia (COSA): Evidence-based practice guidelines for the nutritional management of adult patients with head and neck cancer
Japan
●[In English] Pan-Asian adaptation of the European Head and Neck Society (EHNS)-European Society for Medical Oncology (ESMO)-European Society for Radiotherapy and Oncology (ESTRO) clinical practice guidelines for the diagnosis, treatment, and follow-up of patients with squamous cell carcinoma of the head and neck (2021)
●[In Japanese] Japan Society for Head and Neck Cancer (JSHNC): Head and neck cancer practice guidelines (2018)
●[In Japanese] Japanese Society of Medical Oncology (JSMO): Head and neck cancer drug therapy guidance, 2nd edition (2018)
